GB0503566D0 - Treatment for cancer - Google Patents

Treatment for cancer

Info

Publication number
GB0503566D0
GB0503566D0 GB0503566A GB0503566A GB0503566D0 GB 0503566 D0 GB0503566 D0 GB 0503566D0 GB 0503566 A GB0503566 A GB 0503566A GB 0503566 A GB0503566 A GB 0503566A GB 0503566 D0 GB0503566 D0 GB 0503566D0
Authority
GB
United Kingdom
Prior art keywords
cancer
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0503566A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Neutec Pharma Ltd
Original Assignee
Neutec Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neutec Pharma Ltd filed Critical Neutec Pharma Ltd
Priority to GB0503566A priority Critical patent/GB0503566D0/en
Publication of GB0503566D0 publication Critical patent/GB0503566D0/en
Priority to CNA2005800292973A priority patent/CN101010100A/en
Priority to RU2007104053/15A priority patent/RU2389507C2/en
Priority to US11/630,936 priority patent/US20080038267A1/en
Priority to JP2007518687A priority patent/JP2008504355A/en
Priority to SG200904521-2A priority patent/SG153877A1/en
Priority to NZ552508A priority patent/NZ552508A/en
Priority to PCT/GB2005/002545 priority patent/WO2006003384A1/en
Priority to CA002572318A priority patent/CA2572318A1/en
Priority to EP05756172A priority patent/EP1763366A1/en
Priority to BRPI0512889-7A priority patent/BRPI0512889A/en
Priority to KR1020077002582A priority patent/KR20070050918A/en
Priority to AU2005259002A priority patent/AU2005259002B2/en
Priority to MX2007000263A priority patent/MX2007000263A/en
Priority to MA29587A priority patent/MA28701B1/en
Priority to IL180460A priority patent/IL180460A/en
Priority to NO20070580A priority patent/NO20070580L/en
Priority to ECSP077219 priority patent/ECSP077219A/en
Ceased legal-status Critical Current

Links

GB0503566A 2004-07-02 2005-02-21 Treatment for cancer Ceased GB0503566D0 (en)

Priority Applications (18)

Application Number Priority Date Filing Date Title
GB0503566A GB0503566D0 (en) 2005-02-21 2005-02-21 Treatment for cancer
MX2007000263A MX2007000263A (en) 2004-07-02 2005-06-30 Treatment of cancer.
CA002572318A CA2572318A1 (en) 2004-07-02 2005-06-30 Treatment of cancer
BRPI0512889-7A BRPI0512889A (en) 2004-07-02 2005-06-30 use of an antibody or antigen binding fragment thereof and at least one anticancer agent, combined preparation, and methods of treating cancer and leukemia
US11/630,936 US20080038267A1 (en) 2004-07-02 2005-06-30 Treatment Of Cancer
JP2007518687A JP2008504355A (en) 2004-07-02 2005-06-30 Cancer treatment
SG200904521-2A SG153877A1 (en) 2004-07-02 2005-06-30 Treatment of cancer
NZ552508A NZ552508A (en) 2004-07-02 2005-06-30 Treatment of cancer with pharmaceutical agents together with anti-Hsp 90 antibodies
PCT/GB2005/002545 WO2006003384A1 (en) 2004-07-02 2005-06-30 Treatment of cancer
CNA2005800292973A CN101010100A (en) 2004-07-02 2005-06-30 Treatment of cancer
EP05756172A EP1763366A1 (en) 2004-07-02 2005-06-30 Treatment of cancer
RU2007104053/15A RU2389507C2 (en) 2004-07-02 2005-06-30 Cancer treatment
KR1020077002582A KR20070050918A (en) 2004-07-02 2005-06-30 Treatment of cancer
AU2005259002A AU2005259002B2 (en) 2004-07-02 2005-06-30 Treatment of cancer
MA29587A MA28701B1 (en) 2004-07-02 2006-12-29 TREATMENT OF CANCER
IL180460A IL180460A (en) 2004-07-02 2006-12-31 COMBINED PREPARATION FOR TREATING CANCER COMPRISING AN ANTI-Hsp90 ANTIBODY AND AT LEAST ONE ANTI-CANCER AGENT
NO20070580A NO20070580L (en) 2004-07-02 2007-01-31 Treatment of cancer.
ECSP077219 ECSP077219A (en) 2004-07-02 2007-02-02 CANCER TREATMENT

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0503566A GB0503566D0 (en) 2005-02-21 2005-02-21 Treatment for cancer

Publications (1)

Publication Number Publication Date
GB0503566D0 true GB0503566D0 (en) 2005-03-30

Family

ID=34401066

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0503566A Ceased GB0503566D0 (en) 2004-07-02 2005-02-21 Treatment for cancer

Country Status (1)

Country Link
GB (1) GB0503566D0 (en)

Similar Documents

Publication Publication Date Title
ZA200805877B (en) Pyridiazinone derivatives for tumour treatment
ZA200800907B (en) Treatment of cancer
IL190882A0 (en) Compositions for cancer therapy
PT1830847E (en) Treatment for cancer
HK1110477A1 (en) Methods for treating drug resistant cancer
GB0516068D0 (en) Well treatment
HK1110224A1 (en) Therapeutic agent for cancer
IL189377A0 (en) Combinations comprising dmxaa for the treatment of cancer
IL189376A0 (en) Combinations comprising dmxaa for the treatment of cancer
EP2088862A4 (en) Cancer treatment method
GB0428187D0 (en) Cancer treatment
GB0511769D0 (en) Treatment
GB0525540D0 (en) New treatment
GB0413346D0 (en) Treating cancer
IL187792A0 (en) 4-anilino-3-quinolinecarbonitriles for the treatment of cancer
GB0520067D0 (en) Treatment of cancer
GB0502171D0 (en) Well treatment
HK1225304A1 (en) Treating bone cancer
ZA200805522B (en) Dioxoiane dérivates for the treatment of cancer
GB0525535D0 (en) Tumour treatment
GB0707556D0 (en) Treatment for cancer
GB0507685D0 (en) Cancer treatment
GB0404675D0 (en) Cancer treatment
GB0517386D0 (en) Combinations for the treatment of cancer
GB0710871D0 (en) Cancer treatment

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)